Silo Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.9	4.75	3.91	3.52	11.37	9.84
Short-Term Investments	2.13	2.11	3.17	4.14	0	0.42
Cash & Short-Term Investments	6.03	6.86	7.08	7.67	11.37	10.26
Cash Growth	10.65%	-3.13%	-7.63%	-32.58%	10.85%	808.83%
Accounts Receivable	-	0	0	0	0	0
Receivables	-	0	0	0	0.07	0
Prepaid Expenses	0.53	0.19	0.03	0.01	0.12	0.06
Other Current Assets	0.24	0.34	0.01	0.01	0.02	0.08
Total Current Assets	6.8	7.39	7.11	7.68	11.57	10.4
Other Intangible Assets	0.21	0.22	0.24	-	-	-
Long-Term Accounts Receivable	-	-	0.01	0.01	0.01	0.01
Long-Term Deferred Charges	-	-	0.05	0.06	0.06	0.02
Total Assets	7.02	7.61	7.41	7.75	11.64	10.49
Accounts Payable	0.63	0.58	1.58	0.7	0.22	0.42
Accrued Expenses	-	-	-	-	0.14	-
Current Unearned Revenue	0.07	0.07	0.07	0.07	0.07	0.07
Total Current Liabilities	0.7	0.65	1.66	0.78	0.44	0.49
Long-Term Unearned Revenue	0.63	0.65	0.72	0.79	0.87	0.94
Total Liabilities	1.34	1.3	2.38	1.57	1.3	1.43
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	26.81	25.79	20.3	17.53	17.51	12.32
Retained Earnings	-21.14	-19.49	-15.26	-10.87	-7.17	-3.26
Treasury Stock	-	-	-	-0.47	-	-
Comprehensive Income & Other	0.01	0.01	0	-0.01	-	-
Total Common Equity	5.68	6.31	5.03	6.18	10.34	9.06
Shareholders' Equity	5.68	6.31	5.03	6.18	10.34	9.06
Total Liabilities & Equity	7.02	7.61	7.41	7.75	11.64	10.49
Net Cash (Debt)	6.03	6.86	7.08	7.67	11.37	10.26
Net Cash Growth	10.65%	-3.13%	-7.63%	-32.58%	10.85%	824.31%
Net Cash Per Share	8.47	12.27	28.86	37.33	74.66	80.20
Filing Date Shares Outstanding	1.08	0.94	0.3	0.19	0.21	0.13
Total Common Shares Outstanding	1.08	0.89	0.3	0.19	0.21	0.13
Working Capital	6.1	6.74	5.46	6.91	11.14	9.91
Book Value Per Share	5.24	7.10	16.84	31.88	49.10	68.91
Tangible Book Value	5.47	6.09	4.79	6.18	10.34	9.06
Tangible Book Value Per Share	5.04	6.86	16.03	31.88	49.10	68.91

SEC Filings: 10-K · 10-Q